Skip to content

Goodwill at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$48.56B+9.2%
Stryker logo
StrykerSYK
$19.19B+0.5%
PDE
Pro-Dex, Inc.PDEX
$6.53M
CONMED logo
CONMEDCNMD
$806.86M+0.1%
Anika Therapeutics logo
Anika TherapeuticsANIK
$7.89M+6.3%
Globus Medical logo
Globus MedicalGMED
$1.44B+0.4%

Segments

By geography

See full
Americas$9.26B
EMEA$1.4B
Asia Pacific$604.4M

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.44B-7.4%
Enterprise value$24.49B-5.2%
P/E22.9×0.0×
P/S2.1×-0.3×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's goodwill?
Zimmer Biomet Holdings (ZBH) reported goodwill of $9.93B in Q1 2026.
How has Zimmer Biomet Holdings's goodwill changed year-over-year?
Zimmer Biomet Holdings's goodwill increased by 10.5% year-over-year, from $8.99B to $9.93B.
What is the long-term trend for Zimmer Biomet Holdings's goodwill?
Over 5 years (2020 to 2025), Zimmer Biomet Holdings's goodwill has grown at a 2.1% compound annual growth rate (CAGR), from $8.98B to $9.95B.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.